VERU INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
VERU INC. (VERU) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 66.75 million shares for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-12-10
- VERU INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 69.89M shares, a 7.42% increase year-over-year.
- VERU INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 66.73M shares, a 6.06% increase year-over-year.
- VERU INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 65.37M shares, a 4.14% increase year-over-year.
- VERU INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 65.04M shares, a 3.97% increase year-over-year.
- VERU INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 66.75M shares, a 5.42% increase from fiscal 2019.
- VERU INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 63.32M shares, a 17.57% increase from fiscal 2018.
- VERU INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 53.86M shares, a 55.49% increase from fiscal 2017.
- VERU INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 34.64M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-09-30 | 69.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | 68.31M shares derived: average of 2 quarters · filed 2020-12-10 | 67.33M shares derived: average of 3 quarters · filed 2020-12-10 | 66.75M shares 10-K · filed 2020-12-10 |
| 2020-06-30 | 66.73M shares 10-Q · filed 2020-08-13 | 66.05M shares derived: average of 2 quarters · filed 2020-08-13 | 65.71M shares 10-Q · filed 2020-08-13 | 65.55M shares derived: average of 4 quarters · filed 2020-12-10 |
| 2020-03-31 | 65.37M shares 10-Q · filed 2020-05-13 | 65.20M shares 10-Q · filed 2020-05-13 | 65.15M shares derived: average of 3 quarters · filed 2020-12-10 | 64.59M shares derived: average of 4 quarters · filed 2020-12-10 |
| 2019-12-31 | 65.04M shares 10-Q · filed 2020-02-12 | 65.05M shares derived: average of 2 quarters · filed 2020-12-10 | 64.34M shares derived: average of 3 quarters · filed 2020-12-10 | 63.94M shares derived: average of 4 quarters · filed 2020-12-10 |
| 2019-09-30 | 65.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | 63.99M shares derived: average of 2 quarters · filed 2020-12-10 | 63.58M shares derived: average of 3 quarters · filed 2020-12-10 | 63.32M shares 10-K · filed 2020-12-10 |
| 2019-06-30 | 62.92M shares 10-Q · filed 2020-08-13 | 62.84M shares derived: average of 2 quarters · filed 2020-08-13 | 62.75M shares 10-Q · filed 2020-08-13 | 60.85M shares derived: average of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | 62.77M shares 10-Q · filed 2020-05-13 | 62.66M shares 10-Q · filed 2020-05-13 | 60.16M shares derived: average of 3 quarters · filed 2020-05-13 | 58.57M shares derived: average of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | 62.55M shares 10-Q · filed 2020-02-12 | 58.85M shares derived: average of 2 quarters · filed 2020-02-12 | 57.16M shares derived: average of 3 quarters · filed 2020-02-12 | 56.21M shares derived: average of 4 quarters · filed 2020-02-12 |
| 2018-09-30 | 55.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | 54.47M shares derived: average of 2 quarters · filed 2019-12-12 | 54.10M shares derived: average of 3 quarters · filed 2019-12-12 | 53.86M shares 10-K · filed 2019-12-12 |
| 2018-06-30 | 53.79M shares 10-Q · filed 2019-08-08 | 53.57M shares derived: average of 2 quarters · filed 2019-08-08 | 53.43M shares 10-Q · filed 2019-08-08 | 51.48M shares derived: average of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | 53.36M shares 10-Q · filed 2019-05-15 | 53.25M shares 10-Q · filed 2019-05-15 | 50.71M shares derived: average of 3 quarters · filed 2019-05-15 | 45.78M shares derived: average of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | 53.15M shares 10-Q · filed 2019-02-13 | 49.38M shares derived: average of 2 quarters · filed 2019-02-13 | 43.25M shares derived: average of 3 quarters · filed 2019-02-13 | 40.18M shares derived: average of 4 quarters · filed 2019-02-13 |
| 2017-09-30 | 45.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | 38.30M shares derived: average of 2 quarters · filed 2018-12-13 | 35.86M shares derived: average of 3 quarters · filed 2018-12-13 | 34.64M shares 10-K · filed 2018-12-13 |
| 2017-06-30 | 30.99M shares 10-Q · filed 2018-08-14 | 30.99M shares derived: average of 2 quarters · filed 2018-08-14 | 30.98M shares 10-Q · filed 2018-08-14 | |
| 2017-03-31 | 30.98M shares 10-Q · filed 2018-05-11 | 30.98M shares 10-Q · filed 2018-05-11 | ||
| 2016-12-31 | 30.98M shares 10-Q · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |